Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-02-05

Clinical Trial Update: Hepatocyte Growth Factor (HGF) Concentration in Myocardial Infarction

View source ↗

Summary

A completed study evaluated hepatocyte growth factor (HGF) concentrations in acute coronary syndrome and myocardial infarction patients. The update confirms tri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hepatocyte Growth Factor (hepatocyte growth factor)

Snippet

Sponsor: National Institute of Cardiology, Warsaw, Poland | Conditions: Acute Coronary Syndrome, Myocardial Infarction | Status: COMPLETED